Unilateral recognition on Tech is totally different beast from Pharma. This is because different nature of issues. In Pharma, main issue testing, which is bas

Unilateral recognition on Tech is totally different beast from Pharma. This is because different nature of issues. In Pharma, main issue testing, which is basically very human-intensive task, at the moment machines are not involved. And mostly talking on drugs, we trying hard to achieve "invisible" drugs, which have extremely narrow appearance (as in space as in time), so ideally, drug make it's action extremely short time, after which no effects appear. So, ideal drug, does not have any side effects at all. In Tech, difference, it almost whole side effects. 1. Building starts with choose good place - using lot of sources to gather info, and sources see this and react. 2. Continued with negotiations, with interested parties (persons and entities), and on so large and sophisticated project, need to make some parties allies. 3. Building itself, involve lot of parties. Some parties making profits, other demand compensations. 4. All buildings have limited productive lifetime, after which appear decommission and in ideal case, annihilation of building and return land to some "first use" state, now most people consider wild nature state. Imagine world, where you must negotiate with ALL people on your street usage of anti-flu drugs, including all possible side effects and all following effects, like attending of gym, etc :)